DR. GROVER CARLTON BAGBY, MD
Osteopathic Medicine at Sam Jackson Park Rd, Portland, OR

License number
Oregon MD07879
Category
Osteopathic Medicine
Type
Hematology
Address
Address
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Phone
(503) 494-6594
(503) 248-9216
(503) 721-7946 (Fax)

Personal information

See more information about GROVER CARLTON BAGBY at radaris.com
Name
Address
Phone
Grover Bagby
13021 SE River Rd STE 4000, Portland, OR 97222
(503) 652-6536
Grover Bagby
3738 NE Couch St, Portland, OR 97232
(503) 248-9216
Grover Bagby, age 82
3738 SW Council Crest Dr, Portland, OR 97239
(503) 248-9216

Professional information

Grover Bagby Photo 1

Professor Of Medicine And Molecular Genetics At Oregon Health And Science University

Position:
Nominating Committee Member at American Society of Hematology, Professor of Medicine and Molecular Genetics at Oregon Health and Science University
Location:
Portland, Oregon Area
Industry:
Research
Work:
American Society of Hematology since 2011 - Nominating Committee Member Oregon Health and Science University since Jul 1976 - Professor of Medicine and Molecular Genetics Oregon Health and Science University 1992 - 2007 - Cancer Institute Director Oregon Health and Science University Aug 1985 - Jul 1995 - Head, Division of Hematology and Medical Oncology
Education:
Oregon Health and Science University 1974 - 1976
Oregon Health and Science University 1970 - 1971
Baylor College of Medicine 1968 - 1970
Baylor College of Medicine 1964 - 1968
M.D., Medicine
Pomona College 1960 - 1964
B.A>, Zoology (Pre Med)
Honor & Awards:
Alpha Omega Alpha American Society of Clinical Investigation Association of American Physicians Pomona College Athletic Hall of Fame President, International Society for Experimental Hematology (2000) Associate Editor, Blood (2002-2012)


Grover Carlton Bagby Photo 2

Grover Carlton Bagby, Portland OR

Specialties:
Hematologist
Address:
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
Education:
Baylor University, College of Medicine - Doctor of Medicine*
Sacred Heart Medical Center-University District - Fellowship - Hematology*
Sacred Heart Medical Center-University District - Residency - Family Medicine*
Baylor University Medical Center - Residency - Family Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)*


Grover C Bagby Photo 3

Dr. Grover C Bagby, Portland OR - MD (Doctor of Medicine)

Specialties:
Hematology
Address:
3181 SW Sam Jackson Park Rd SUITE CR145, Portland 97239
(503) 494-8311 (Phone), (503) 494-7086 (Fax)
VETERANS AFFAIRS MEDICAL CENTE
3710 SW Us Veterans Hospital Rd, Portland 97239
(503) 273-5318 (Phone)
Certifications:
Hematology, 1976, Internal Medicine, 1972
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
3181 SW Sam Jackson Park Rd SUITE CR145, Portland 97239
VETERANS AFFAIRS MEDICAL CENTE
3710 SW Us Veterans Hospital Rd, Portland 97239
OHSU Hospital
3181 West Sam Jackson Park Rd, Portland 97239
Education:
Medical School
Baylor University
Graduated: 1968
Ben Taub Genl Hosp
Baylor Affil Hosps
U Oregon Hosps


Grover Bagby Photo 4

Test For Ovarian Cancer By Detecting Abnormality In Fancd2 Pathway

US Patent:
2009030, Dec 10, 2009
Filed:
May 2, 2007
Appl. No.:
12/299233
Inventors:
Grover C. Bagby - Portland OR, US
Tanja Pejovic - Portland OR, US
Laura Hays - Portland OR, US
Susan Olson - Portland OR, US
International Classification:
C12Q 1/68, C12Q 1/02, C40B 30/04, G01N 33/574
US Classification:
435 6, 435 29, 506 9, 435 723
Abstract:
Methods are provided for determining diagnosing ovarian and breast cancer in a subject, including diagnosing the predisposition of a subject's risk of developing breast or ovarian cancer. The methods include selecting a subject, for example a subject with one or more risk factors for developing ovarian cancer or breast cancer, and detecting a decrease in the activity of the Fanconi anemia (FA) non-nuclear core (NNC) component in the subject. Such a decrease is indicative of a predisposition to ovarian cancer and/or breast cancer in the subject. These methods can be used to monitor the response of a subject to agents designed to prevent breast and ovarian cancer, for example an anti-neoplastic agent. Methods also are provided for identifying agents of use in preventing breast and ovarian cancer.